Furthermore, CD11b+ T cells are found to possess a fully-activated effector phenotype and have been detected in scenarios of chronic antigenic stimulation, such as in persistent bacterial or viral infections and neoadjuvant cancer therapy [41]-[46]. The gene discussed is ITGAM; the disease is cancer.